株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

液体生検市場 - 世界市場規模、シェア、発展、成長、需要予測(2018~2026年)

Liquid Biopsy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

発行 Transparency Market Research 商品コード 719515
出版日 ページ情報 英文 161 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=110.80円で換算しております。
Back to Top
液体生検市場 - 世界市場規模、シェア、発展、成長、需要予測(2018~2026年) Liquid Biopsy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
出版日: 2018年08月22日 ページ情報: 英文 161 Pages
概要

当レポートでは、世界の液体生検市場について調査し、市場の現状と2026年までの成長予測、セグメント別動向、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 序論

第2章 仮定と調査方法

第3章 エグゼクティブサマリー

第4章 市場概要

  • 市場タキソノミー
  • 市場規模予測
  • 市場見通し
  • 主な業界イベント

第5章 市場動向

  • 概要分析
  • 促進因子
  • 阻害因子
  • 機会
  • 主な動向
  • 実践的考察
  • 液体生検ワークフロー
  • 眼の疫学
  • 医療概要
  • 循環バイオマーカーの種類とその生検可能性

第6章 用途別市場分析

  • 主な調査結果
  • イントロダクション
  • 市場価値予測
  • 市場予測
    • 腫瘍
    • NIPT
    • 移植診断
    • その他
  • 市場の魅力度分析

第7章 循環バイオマーカー別市場分析

  • 主な調査結果
  • イントロダクション
  • 市場価値予測
  • 市場価値
    • 循環腫瘍細胞
    • 自由核酸
    • エキソソーム
  • 市場の魅力度分析

第8章 エンドユーザー別市場分析

  • イントロダクション
  • 市場価値予測
  • 市場予測
    • 病院
    • 参照試験所
    • 学術研究機関
    • その他
  • 市場の魅力度分析

第9章 地域別市場分析

  • 市場価値予測
  • 市場予測
  • 市場の魅力度分析

第10章 北米市場

第11章 欧州市場

第12章 アジア太平洋地域市場

第13章 ラテンアメリカ市場

第14章 中東・アフリカ市場

第15章 企業プロファイル

  • 競合マトリクス
  • 企業プロファイル
    • Biocept, Inc.
    • MDxHealth
    • Myriad Genetics, Inc.
    • Bio-Rad Laboratories
    • QIAGEN
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Genomic Health, Inc.
    • Illumina, Inc.
図表

List of Tables

  • Table 01: Comparison of Liquid Biopsy and Tissue Biopsy: Practical Considerations
  • Table 02: Comparison of Different Classes of Circulating Biomarkers and their Potential for Liquid Biopsy
  • Table 03: Global Liquid Biopsy Market Value (US$ Mn) Forecast, by Application, 2016-2026
  • Table 04: Global Liquid Biopsy Market Value (US$ Mn) Forecast, by Oncology, 2016-2026
  • Table 05: Global Liquid Biopsy Market Value (US$ Mn) Forecast, by Circulating Biomarker, 2016-2026
  • Table 06: Global Liquid Biopsy Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 07: Global Liquid Biopsy Market Value (US$ Mn) Forecast, by Region, 2016-2026
  • Table 08: North America Liquid Biopsy Market Value (US$ Mn) Forecast, by Application, 2018-2026
  • Table 09: North America Liquid Biopsy Market Value (US$ Mn) Forecast, by Oncology, 2016-2026
  • Table 10: North America Liquid Biopsy Market Value (US$ Mn) Forecast, by Circulating Biomarkers, 2016-2026
  • Table 11: North America Liquid Biopsy Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 12: North America Liquid Biopsy Market Value (US$ Mn) Forecast, by Country, 2016-2026
  • Table 13: Europe Liquid Biopsy Market Value (US$ Mn) Forecast, by Application, 2018-2026
  • Table 14: Europe Liquid Biopsy Market Value (US$ Mn) Forecast, by Oncology, 2016-2026
  • Table 15: Europe Liquid Biopsy Market Value (US$ Mn) Forecast, by Circulating Biomarkers, 2016-2026
  • Table 16: Europe Liquid Biopsy Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 17: Europe Liquid Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2016-2026
  • Table 18: Asia Pacific Liquid Biopsy Market Value (US$ Mn) Forecast, by Application, 2018-2026
  • Table 19: Asia Pacific Liquid Biopsy Market Value (US$ Mn) Forecast, by Oncology, 2016-2026
  • Table 20: Asia Pacific Liquid Biopsy Market Value (US$ Mn) Forecast, by Circulating Biomarkers, 2016-2026
  • Table 21: Asia Pacific Liquid Biopsy Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 22: Asia Pacific Liquid Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2016-2026
  • Table 23: Latin America Liquid Biopsy Market Value (US$ Mn) Forecast, by Application, 2016-2026
  • Table 24: Latin America Liquid Biopsy Market Value (US$ Mn) Forecast, by Oncology, 2016-2026
  • Table 25: Latin America Liquid Biopsy Market Value (US$ Mn) Forecast, by Circulating Biomarker, 2016-2026
  • Table 26: Latin America Liquid Biopsy Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 27: Latin America Liquid Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 28: Middle East & Africa Liquid Biopsy Market Value (US$ Mn) Forecast, by Application, 2018-2026
  • Table 29: Middle East & Africa Liquid Biopsy Market Value (US$ Mn) Forecast, by Oncology, 2016-2026
  • Table 30: Middle East & Africa Liquid Biopsy Market Value (US$ Mn) Forecast, by Circulating Biomarkers, 2016-2026
  • Table 31: Middle East & Africa Liquid Biopsy Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 32: Middle East & Africa Liquid Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2016-2026

List of Figures

  • Figure 01: Global Liquid Biopsy Market Snapshot
  • Figure 02: Global Liquid Biopsy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2016-2026
  • Figure 03: Global Liquid Biopsy Market Value Share by Application (2017)
  • Figure 04: Global Liquid Biopsy Market Value Share by Circulating Biomarker (2017)
  • Figure 05: Global Liquid Biopsy Market Value Share by End-user (2017)
  • Figure 06: Global Liquid Biopsy Market Value Share by Region (2017)
  • Figure 07: Global Liquid Biopsy Market Value Share, by Application, 2017 and 2026
  • Figure 08: Global Liquid Biopsy Market Value Share, by Oncology, 2017 and 2026
  • Figure 09: Global Liquid Biopsy Market Revenue (US$ Mn) 9Forecast and Y-o-Y Growth (%) Projection, by Oncology, 2016-2026
  • Figure 10: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by NIPT, 2016-2026
  • Figure 11: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Transplant Diagnostics, 2016-2026
  • Figure 12: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2016-2026
  • Figure 13: Global Liquid Biopsy Market Attractiveness, by Application
  • Figure 14: Global Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker, 2017 and 2026
  • Figure 15: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Circulating Tumor cells (CTC), 2016-2026
  • Figure 16: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Free Nucleic Acid, 2016-2026
  • Figure 17: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Extracellular Vesicles, 2016-2026
  • Figure 18: Global Liquid Biopsy Market Attractiveness Analysis, by Circulating Biomarker
  • Figure 19: Global Liquid Biopsy Market Value Share, by End-user, 2017 and 2026
  • Figure 20: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospitals, 2018-2026
  • Figure 21: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Reference Laboratories, 2018-2026
  • Figure 22: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Academic and Research Institutes, 2018-2026
  • Figure 23: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2018-2026
  • Figure 24: Global Liquid Biopsy Market Attractiveness, by End-user
  • Figure 25: Global Liquid Biopsy Market Value Share, by Region, 2017 and 2026
  • Figure 26: Global Liquid Biopsy Market Attractiveness, by Region, 2018-2026
  • Figure 27: North America Liquid Biopsy Market Value (US$ Mn) Forecast, 2016-2026
  • Figure 28: North America Liquid Biopsy Market Attractiveness Analysis, by Country
  • Figure 29: North America Liquid Biopsy Market Value Share Analysis, by Application, 2017 and 2026
  • Figure 30: North America Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker, 2017 and 2026
  • Figure 31: North America Liquid Biopsy Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 32: North America Liquid Biopsy Market Value Share Analysis, by Country, 2017 and 2026
  • Figure 33: North America Liquid Biopsy Market Attractiveness Analysis, by Application, 2018-2026
  • Figure 34: North America Liquid Biopsy Market Attractiveness Analysis, by Circulating Biomarker, 2018-2026
  • Figure 35: North America Liquid Biopsy Market Attractiveness Analysis, by End-user, 2018-2026
  • Figure 36: Europe Liquid Biopsy Market Value (US$ Mn) Forecast, 2016-2026
  • Figure 37: Europe Market Liquid Biopsy Attractiveness Analysis, by Country/Sub-Region
  • Figure 38: Europe Liquid Biopsy Market Value Share Analysis, by Application, 2017 and 2026
  • Figure 39: Europe Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker, 2017 and 2026
  • Figure 40: Europe Liquid Biopsy Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 41: Europe Liquid Biopsy Market Value Share Analysis, by Country/Sub-Region, 2017 and 2026
  • Figure 42: Europe Liquid Biopsy Market Attractiveness Analysis, by Application, 2018-2026
  • Figure 43: Europe Liquid Biopsy Market Attractiveness Analysis, by Circulating Biomarker, 2018-2026
  • Figure 44: Europe Liquid Biopsy Market Attractiveness Analysis, by End-user, 2018-2026
  • Figure 45: Asia Pacific Liquid Biopsy Market Value (US$ Mn) Forecast, 2016-2026
  • Figure 46: Asia Pacific Liquid Biopsy Market Attractiveness Analysis, by Country/Sub-Region
  • Figure 47: Asia Pacific Liquid Biopsy Market Value Share Analysis, by Application, 2017 and 2026
  • Figure 48: Asia Pacific Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker, 2017 and 2026
  • Figure 49: Asia Pacific Liquid Biopsy Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 50: Asia Pacific Liquid Biopsy Market Value Share Analysis, by Country/Sub-Region, 2017 and 2026
  • Figure 51: Asia Pacific Liquid Biopsy Market Attractiveness Analysis, by Application, 2018-2026
  • Figure 52: Asia Pacific Liquid Biopsy Market Attractiveness Analysis, by Circulating Biomarker, 2018-2026
  • Figure 53: Asia Pacific Liquid Biopsy Market Attractiveness Analysis, by End-user, 2018-2026
  • Figure 54: Latin America Liquid Biopsy Market Value (US$ Mn) Forecast, 2016-2026
  • Figure 55: Latin America Market Attractiveness Analysis, by Country/Sub-region
  • Figure 56: Latin America Liquid Biopsy Market Value Share Analysis, by Application, 2017 and 2026
  • Figure 57: Latin America Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker, 2017 and 2026
  • Figure 58: Latin America Liquid Biopsy Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 59: Latin America Liquid Biopsy Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 60: Latin America Liquid Biopsy Market Attractiveness Analysis, by Application, 2018-2026
  • Figure 61: Latin America Liquid Biopsy Market Attractiveness Analysis, by Circulating Biomarker, 2018-2026
  • Figure 62: Latin America Liquid Biopsy Market Attractiveness Analysis, by End-user, 2018-2026
  • Figure 63: Middle East & Africa Liquid Biopsy Market Value (US$ Mn) Forecast, 2016-2026
  • Figure 64: Middle East & Africa Market Attractiveness Analysis, by Country/Sub-Region
  • Figure 65: Middle East & Africa Liquid Biopsy Market Value Share Analysis, by Application, 2017 and 2026
  • Figure 66: Middle East & Africa Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker, 2017 and 2026
  • Figure 67: Middle East & Africa Liquid Biopsy Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 68: Middle East & Africa Liquid Biopsy Market Value Share Analysis, by Country/Sub-Region, 2017 and 2026
  • Figure 69: Middle East & Africa Liquid Biopsy Market Attractiveness Analysis, by Application, 2018-2026
  • Figure 70: Middle East & Africa Liquid Biopsy Market Attractiveness Analysis, by Circulating Biomarker, 2018-2026
  • Figure 71: Middle East & Africa Liquid Biopsy Market Attractiveness Analysis, by End-user, 2018-2026
目次

Title:
Liquid Biopsy Market (Application - Oncology, NIPT, Transplant Diagnostics; Circulating Biomarker - Circulating Tumor Cells (CTC), Free Nucleic Acid, Extracellular Vesicles; End use - Hospitals, Reference Laboratories, Academic and Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026.

Liquid Biopsy Market: Scope and Methodology

This report on the global liquid biopsy market analyzes the current and future prospects of the market. The report comprises a comprehensive executive summary, including a market snapshot that provides overall information of various segments. The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2016 to 2026, considering the macro and micro environmental factors. Growth rates for each segment within the global liquid biopsy market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. The report also provides insights into the key trends of the liquid biopsy market such as rise in prevalence of cancer, increasing applications of liquid biopsy, advantages of liquid biopsy over tumor biopsy and improvement in health care infrastructure in emerging economies. Key market indicators influencing the global liquid biopsy market including cost constraints and regulatory landscape have been taken into consideration. The report also includes market attractiveness analysis of the major segments that provides a thorough analysis of the overall competitive scenario in the global liquid biopsy market.

Market revenue in terms of US$ Mn for the period between 2016 and 2026 along with the compound annual growth rate (CAGR %) from 2018 to 2026 are provided for all the segments, considering 2017 as the base year. The year-on-year growth of the global liquid biopsy market for each segment is also reflected. Additionally, market-related factors such as favorable reimbursement scenario, expanding applications in chronic diseases and historical year-on-year growth have been taken into consideration while estimating the market size.

Liquid Biopsy Market: Segmentation

Based on application, the global liquid biopsy market has been segmented into oncology, NIPT, transplant diagnostics, and others. In terms of circulating biomarkers, the global liquid biopsy market has been classified into circulating tumor cells (CTC), free nucleic acid, and extracellular vesicles (exosomes). In terms of end-user, the market has been segregated into hospitals, reference laboratories, academic and research institutes, and others.

In terms of region, the global liquid biopsy market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Additionally, the regions have been further segmented into major countries in each of the regions. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Australia, Japan, India, Brazil, GCC, South Africa, and Mexico.

Liquid Biopsy Market: Competitive Landscape

The report also profiles major players in the liquid biopsy market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Biocept, Inc., MDxHealth, Myriad Genetics, Inc., Bio-Rad Laboratories, QIAGEN, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Genomic Health, Inc., and Illumina, Inc.

The global liquid biopsy market has been segmented as follows:

Global Liquid Biopsy Market, by Application

  • Oncology
  • NIPT
  • Transplant Diagnostics
  • Others

Global Liquid Biopsy Market, by Circulating Biomarker

  • Circulating Tumor Cells (CTC)
  • Free Nucleic Acid
  • Extracellular vesicles/Exosomes

Global Liquid Biopsy Market, by End-user

  • Hospitals
  • Reference Laboratories
  • Academic and Research Institutes
  • Others

Global Liquid Biopsy Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Australia & New Zealand
    • Japan
    • China
    • India
    • Rest of Asia pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Israel
    • Rest of Middle East & Africa

Table of Contents

Section 1 Preface

  • 1.1 Report Scope and Market Segmentation
  • 1.2 Research Highlights

Section 2 Assumptions and Research Methodology

  • 2.1 Assumptions
  • 2.2 Research Methodology

Section 3 Executive Summary

  • 3.1 Global Liquid Biopsy Market Snapshot
  • 3.2 Market Share Analysis by Region, 2017

Section 4 Market Overview

  • 4.1 Liquid Biopsy Market Taxonomy
  • 4.2 Global Liquid Biopsy Market Size (US$ Mn) Forecast, 2016-2026
  • 4.3 Global Liquid Biopsy Market: Market Outlook
  • 4.4 Key Industry Events

Section 5 Market Dynamics

  • 5.1 Drivers and Restraints Snapshot Analysis
  • 5.2 Drivers
  • 5.3 Restraints
  • 5.4 Key Trends
  • 5.5 Comparison of Liquid Biopsy and Tissue Biopsy: Practical Considerations
  • 5.6 Liquid Biopsy Workflow
  • 5.7 Cancer Epidemiology (Region wise)
  • 5.8 Healthcare Overview
  • 5.9. Comparison of Different Classes of Circulating Biomarkers and their Potential for Liquid Biopsy

Section 6 Liquid Biopsy Market Analysis, by Application

  • 6.1 Key Findings
  • 6.2 Introduction
  • 6.3 Global Liquid Biopsy Market Value Share Analysis, by Application
  • 6.4 Global Liquid Biopsy Market Forecast, by Application
    • 6.4.1 Global Liquid Biopsy Market Value Share Analysis, by Oncology
      • 6.4.1.1 Global Liquid Biopsy Market Forecast, by Oncology
  • 6.5 Global Liquid Biopsy Market Forecast, by Application
    • 6.5.1 Oncology
    • 6.5.2 NIPT
    • 6.5.3 Transplant Diagnostics
    • 6.5.4 Others
  • 6.6 Global Liquid Biopsy Market Attractiveness Analysis, by Application

Section 7 Global Liquid Biopsy Market Analysis, by Circulating Biomarkers

  • 7.1 Key Findings
  • 7.2 Introduction
  • 7.3 Global Liquid Biopsy Market Value Share Analysis, by Circulating Biomarkers
  • 7.4 Global Liquid Biopsy Market Forecast, by Circulating Biomarkers
    • 7.4.1 Circulating Tumor Cells (CTC)
    • 7.4.2 Free Nucleic Acid
    • 7.4.3 Exosomes
  • 7.5 Global Liquid Biopsy Market Attractiveness Analysis, by Circulating Biomarkers

Section 8 Global Liquid Biopsy Market Analysis, by End-user

  • 8.1 Introduction
  • 8.2 Global Liquid Biopsy Market Value Share Analysis, by End-user
  • 8.3 Global Liquid Biopsy Market Forecast, by End-user
    • 8.3.1 Hospitals
    • 8.3.2 Reference Laboratories
    • 8.3.3 Academic and research institutes
    • 8.3.4 Others
  • 8.4 Global Liquid Biopsy Market Attractiveness Analysis, by Circulating Biomarkers

Section 9 Global Liquid Biopsy Market Analysis, by Region

  • 9.1 Global Liquid Biopsy Market Value Share Analysis, by Region
  • 9.2 Global Liquid Biopsy Market Forecast, by Region
  • 9.3 Global Liquid Biopsy Market Attractiveness Analysis, by Region

Section 10 North America Liquid Biopsy Market Analysis

  • 10.1 North America Liquid Biopsy Market Overview
  • 10.2 North America Liquid Biopsy Market Value Share Analysis, by Application
  • 10.3 North America Liquid Biopsy Market Forecast, by Application
    • 10.3.1 North America Liquid Biopsy Market Forecast, by Oncology
  • 10.4 North America Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker
  • 10.5 North America Liquid Biopsy Market Forecast, by Circulating Biomarkers
  • 10.6 North America Liquid Biopsy Market Value Share Analysis, by End-user
  • 10.7 North America Liquid Biopsy Market Forecast, by End-user
  • 10.8 North America Liquid Biopsy Market Value Share Analysis, by Country
  • 10.9 North America Liquid Biopsy Market Forecast, by Country
    • 10.9.1 U.S.
    • 10.9.2 Canada
  • 10.10 North America Liquid Biopsy Market Attractiveness Analysis
    • 10.10.1 By Country
    • 10.10.2 By Application
    • 10.10.3 By Circulating Biomarker
    • 10.10.4 By End-user

Section 11 Europe Liquid Biopsy Market Analysis

  • 11.1 Europe Liquid Biopsy Market Overview
  • 11.2 Europe Liquid Biopsy Market Value Share Analysis, by Application
  • 11.3 Europe Liquid Biopsy Market Forecast, by Application
    • 11.3.1 Europe Liquid Biopsy Market Forecast, by Oncology
  • 11.4 Europe Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker
  • 11.5 Europe Liquid Biopsy Market Forecast, by Circulating Biomarkers
  • 11.6 Europe Liquid Biopsy Market Value Share Analysis, by End-user
  • 11.7 Europe Liquid Biopsy Market Forecast, by End-user
  • 11.8 Europe Liquid Biopsy Market Value Share Analysis, by Country
  • 11.9 Europe Liquid Biopsy Market Forecast, by Country
    • 11.9.1 Germany
    • 11.9.2 U.K.
    • 11.9.3 France
    • 11.9.4 Spain
    • 11.9.5 Italy
    • 11.9.6 Rest of Europe
  • 11.10 Europe Liquid Biopsy Market Attractiveness Analysis
    • 11.10.1 By Country
    • 11.10.2 By Application
    • 11.10.3 By Circulating Biomarker
    • 11.10.4 By End-user

Section 12 Asia Pacific Liquid Biopsy Market Analysis

  • 12.1 Asia Pacific Liquid Biopsy Market Overview
  • 12.2 Asia Pacific Liquid Biopsy Market Value Share Analysis, by Application
  • 12.3 Asia Pacific Liquid Biopsy Market Forecast, by Application
    • 12.3.1 Asia Pacific Liquid Biopsy Market Forecast, by Oncology
  • 12.4 Asia Pacific Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker
  • 12.5 Asia Pacific Liquid Biopsy Market Forecast, by Circulating Biomarkers
  • 12.6 Asia Pacific Liquid Biopsy Market Value Share Analysis, by End-user
  • 12.7 Asia Pacific Liquid Biopsy Market Forecast, by End-user
  • 12.8 Asia Pacific Liquid Biopsy Market Value Share Analysis, by Country
  • 12.9 Asia Pacific Liquid Biopsy Market Forecast, by Country
    • 12.9.1 China
    • 12.9.2 Japan
    • 12.9.3 India
    • 12.9.4 Australia & New Zealand
    • 12.9.5 Rest of APAC
  • 12.10 Asia Pacific Liquid Biopsy Market Attractiveness Analysis
    • 12.10.1 By Country
    • 12.10.2 By Application
    • 12.10.3 By Circulating Biomarker
    • 12.10.4 By End-user

Section 13 Latin America Liquid Biopsy Market Analysis

  • 13.1 Latin America Liquid Biopsy Market Overview
  • 13.2 Latin America Liquid Biopsy Market Value Share Analysis, by Application
  • 13.3 Latin America Liquid Biopsy Market Forecast, by Application
    • 13.3.1 Latin America Liquid Biopsy Market Forecast, by Oncology
  • 13.4 Latin America Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker
  • 13.5 Latin America Liquid Biopsy Market Forecast, by Circulating Biomarkers
  • 13.6 Latin America Liquid Biopsy Market Value Share Analysis, by End-user
  • 13.7 Latin America Liquid Biopsy Market Forecast, by End-user
  • 13.8 Latin America Liquid Biopsy Market Value Share Analysis, by Country
  • 13.9 Latin America Liquid Biopsy Market Forecast, by Country
    • 13.9.1 Brazil
    • 13.9.2 Mexico
    • 13.9.3 Rest of LATAM
  • 13.10 Latin America Liquid Biopsy Market Attractiveness Analysis
    • 13.10.1 By Country
    • 13.10.2 By Application
    • 13.10.3 By Circulating Biomarker
    • 13.10.3 By End-user

Section 14 Middle East & Africa (MEA) Liquid Biopsy Market Analysis

  • 14.1 Middle East & Africa Liquid Biopsy Market Overview
  • 14.2 Middle East & Africa Liquid Biopsy Market Value Share Analysis, by Application
  • 14.3 Middle East & Africa Liquid Biopsy Market Forecast, by Application
    • 14.3.1 Middle East & Africa Liquid Biopsy Market Forecast, by Oncology
  • 14.4 Middle East & Africa Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker
  • 14.5 Middle East & Africa Liquid Biopsy Market Forecast, by Circulating Biomarkers
  • 14.6 Middle East & Africa Liquid Biopsy Market Value Share Analysis, by End-user
  • 14.7 Middle East & Africa Liquid Biopsy Market Forecast, by End-user
  • 14.8 Middle East & Africa Liquid Biopsy Market Value Share Analysis, by Country
  • 14.9 Middle East & Africa Liquid Biopsy Market Forecast, by Country
    • 14.9.1 GCC
    • 14.9.2 South Africa
    • 14.9.3 Israel
    • 14.9.4 Rest of MEA
  • 14.10 Middle East & Africa Liquid Biopsy Market Attractiveness Analysis
    • 14.10.1 By Country
    • 14.10.2 By Application
    • 14.10.3 By Circulating Biomarker
    • 14.10.4 By End-user

Section 15 Company Profiles

  • 15.1 Competition Matrix
  • 15.2 Company Profiles
    • 15.2.1 Biocept, Inc.
      • 15.2.1.1 Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.1.2 Financial Overview
      • 15.2.1.3 Product Portfolio
      • 15.2.1.4 SWOT Analysis
      • 15.2.1.5 Strategic Overview
    • 15.2.2 MDxHealth
      • 15.2.2.1 Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.2.2 Financial Overview
      • 15.2.2.3 Product Portfolio
      • 15.2.2.4 SWOT Analysis
      • 15.2.2.5 Strategic Overview
    • 15.2.3 Myriad Genetics, Inc.
      • 15.2.3.1 Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.3.2 Financial Overview
      • 15.2.3.3 Product Portfolio
      • 15.2.3.4 SWOT Analysis
      • 15.2.3.5 Strategic Overview
    • 15.2.4 Bio-Rad Laboratories
      • 15.2.4.1 Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.4.2 Financial Overview
      • 15.2.4.3 Product Portfolio
      • 15.2.4.4 SWOT Analysis
      • 15.2.4.5 Strategic Overview
    • 15.2.5 QIAGEN
      • 15.2.5.1 Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.5.2 Financial Overview
      • 15.2.5.3 Product Portfolio
      • 15.2.5.4 SWOT Analysis
      • 15.2.5.5 Strategic Overview
    • 15.2.6 F. Hoffmann-La Roche Ltd.
      • 15.2.6.1 Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.6.2 Financial Overview
      • 15.2.6.3 Product Portfolio
      • 15.2.6.4 SWOT Analysis
      • 15.2.6.5 Strategic Overview
    • 15.2.7 Thermo Fisher Scientific Inc.
      • 15.2.7.1 Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.7.2 Financial Overview
      • 15.2.7.3 Product Portfolio
      • 15.2.7.4 SWOT Analysis
      • 15.2.7.5 Strategic Overview
    • 15.2.8 Genomic Health, Inc.
      • 15.2.8.1 Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.8.2 Financial Overview
      • 15.2.8.3 Product Portfolio
      • 15.2.8.4 SWOT Analysis
      • 15.2.8.5 Strategic Overview
    • 15.2.9 Illumina, Inc.
      • 15.2.9.1 Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.9.2 Financial Overview
      • 15.2.9.3 Product Portfolio
      • 15.2.9.4 SWOT Analysis
      • 15.2.9.5 Strategic Overview
Back to Top